Desipramine Completed Phase 2 Trials for Rett's Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00990691Pilot Study of the Effects of the Desipramine on the Neurovegetative Parameters of the Child With Rett Syndrome